Trials / No Longer Available
No Longer AvailableNCT04599647
EAP for the Treatment of Glioblastoma With PVSRIPO
Expanded Access Protocol for the Treatment of Glioblastoma With PVSRIPO
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Istari Oncology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is an open-label, single-arm, non-randomized, intermediate-sized expanded access study evaluating the safety, efficacy, and tolerability of PVSRIPO delivered via intratumoral infusion, in subjects with glioblastoma (GBM) who are ineligible to participate in clinical study with PVSRIPO that is currently open to enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PVSRIPO | PVSRIPO (5x10\^7 TCID50) delivered intratumorally via convection enhanced delivery (CED). |
Timeline
- First posted
- 2020-10-23
- Last updated
- 2022-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04599647. Inclusion in this directory is not an endorsement.